Martin Shkreli, the former hedge fund manager vilified in nearly every corner of America for buying a pharmaceutical company and jacking up the price of a life-saving drug more than fiftyfold, says he’s auctioning off a chance to slap/punch him in the face to benefit a former friend.
On his Twitter account, Shkreli says he’ll let someone slap/punch him in the face for a price to help benefit his friend Mike, who recently died and left behind a young son who survived cancer.
To make an auction, a person needs to direct message Shkreli on Twitter.
Shkreli has found himself at the center of a firestorm over drug pricing in the last few months, and he hasn’t been afraid to throw on more fuel.
It began after his company, Turing Pharmaceuticals, spent $55 million in August for the U.S. rights to sell Daraprim, a 62-year-old drug for a rare parasitic infection, and promptly raised the price from $13.50 to $750 per pill.